Generation of dual specific bivalent BiTEs (dbBIspecific T-cell engaging antibodies) for cellular immunotherapy.

Maciej KujawskiLin LiSupriyo BhattacharyaPatty WongWen-Hui LeeLindsay WilliamsHarry LiJunie CheaKofi PokuNicole BowlesNagarajan VaidehiPaul YazakiJohn E Shively

Published in: BMC cancer (2019)

dbBiTE redirected T-cell therapy is a promising, efficient approach for targeting and killing cancer cells.

Keyphrases

cell therapy
stem cells
mesenchymal stem cells
cancer therapy
drug delivery
bone marrow